Use of Placebo Control Lilly believes that the use of placebo controls in the development of new medicines can be scientifically valuable and ethically justifiable, provided the use of the placebo meets several key conditions and the decision to conduct a placebo-controlled trial is made after a careful analysis of scientific and ethical considerations, risks to research participants, and local regulatory requirements.